FIGURE 14.
Osteopontin (OPN) expression at the (left) bone-implant interface and (right) in the bulk trabecular structure for (top; (A, B) an active osseointegrative implant specimen, (C, D) the corresponding isotypic controls for the active osseointegrative implant specimen, (E, F) a distant ultrasound treated specimen, and (bottom; (G, H) a passive implant control. Annotations indicate OPN-positive osteocytes (brown cytoplasm; ⊛), OPN-negative osteocytes (blue nuclei; ∗), osteoblasts (⁂), and osteoclasts (✽; visible in image b only).